Arjun Bhadhuri

591 total citations
19 papers, 408 citations indexed

About

Arjun Bhadhuri is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Arjun Bhadhuri has authored 19 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Arjun Bhadhuri's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Global Health Care Issues (3 papers) and Esophageal Cancer Research and Treatment (3 papers). Arjun Bhadhuri is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Global Health Care Issues (3 papers) and Esophageal Cancer Research and Treatment (3 papers). Arjun Bhadhuri collaborates with scholars based in Switzerland, United Kingdom and Netherlands. Arjun Bhadhuri's co-authors include Kate Jolly, Nicola Gale, Adekemi Sekoni, Sue Jowett, Hareth Al‐Janabi, Matthias Schwenkglenks, Becky Pennington, Alison Scope, Ralph P. Insinga and Paola Salari and has published in prestigious journals such as PLoS ONE, BMJ Open and Health Technology Assessment.

In The Last Decade

Arjun Bhadhuri

18 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arjun Bhadhuri Switzerland 9 169 100 83 70 48 19 408
Aviva G. Nathan United States 11 132 0.8× 50 0.5× 53 0.6× 136 1.9× 13 0.3× 21 455
Rachel Adler United States 8 279 1.7× 26 0.3× 89 1.1× 127 1.8× 36 0.8× 23 587
Chien‐Ching Li United States 12 159 0.9× 14 0.1× 76 0.9× 102 1.5× 16 0.3× 29 443
Sarah Wylie United States 10 235 1.4× 13 0.1× 85 1.0× 193 2.8× 66 1.4× 15 539
Chasity Burrows Walters United States 13 260 1.5× 24 0.2× 127 1.5× 130 1.9× 8 0.2× 27 537
Karen Maxwell United Kingdom 9 49 0.3× 18 0.2× 48 0.6× 60 0.9× 20 0.4× 18 282
Anton M. Palma United States 14 39 0.2× 42 0.4× 49 0.6× 93 1.3× 97 2.0× 36 419
Gunna Kilian United States 11 147 0.9× 11 0.1× 101 1.2× 83 1.2× 82 1.7× 15 396
David A. Ramirez United States 10 61 0.4× 12 0.1× 79 1.0× 27 0.4× 23 0.5× 22 394
Bahar Yüksel Türkiye 13 48 0.3× 12 0.1× 45 0.5× 64 0.9× 11 0.2× 35 619

Countries citing papers authored by Arjun Bhadhuri

Since Specialization
Citations

This map shows the geographic impact of Arjun Bhadhuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjun Bhadhuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjun Bhadhuri more than expected).

Fields of papers citing papers by Arjun Bhadhuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arjun Bhadhuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjun Bhadhuri. The network helps show where Arjun Bhadhuri may publish in the future.

Co-authorship network of co-authors of Arjun Bhadhuri

This figure shows the co-authorship network connecting the top 25 collaborators of Arjun Bhadhuri. A scholar is included among the top collaborators of Arjun Bhadhuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arjun Bhadhuri. Arjun Bhadhuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Benčina, Goran, et al.. (2023). Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland. Journal of Medical Economics. 26(1). 283–292. 7 indexed citations
4.
5.
Salari, Paola, Séverine Henrard, Cian O’Mahony, et al.. (2023). Healthcare Costs and Health-Related Quality of Life in Older Multimorbid Patients After Hospitalization. Health Services Insights. 16. 2668058750–2668058750. 3 indexed citations
6.
Salari, Paola, Cian O’Mahony, Séverine Henrard, et al.. (2022). Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study. PLoS ONE. 17(4). e0265507–e0265507. 8 indexed citations
7.
Bhadhuri, Arjun, et al.. (2022). Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland. BMC Health Services Research. 22(1). 837–837. 2 indexed citations
8.
Scope, Alison, Arjun Bhadhuri, & Becky Pennington. (2022). Systematic Review of Cost-Utility Analyses That Have Included Carer and Family Member Health-Related Quality of Life. Value in Health. 25(9). 1644–1653. 19 indexed citations
9.
10.
Palmer, Rebecca, Munyaradzi Dimairo, Nicholas Latimer, et al.. (2020). Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT. Health Technology Assessment. 24(19). 1–176. 34 indexed citations
11.
Bhadhuri, Arjun, Paul Kind, Paola Salari, et al.. (2020). Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Health and Quality of Life Outcomes. 18(1). 33 indexed citations
12.
Latimer, Nicholas, Arjun Bhadhuri, Abualbishr Alshreef, et al.. (2020). Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke: An economic evaluation. Clinical Rehabilitation. 35(5). 703–717. 18 indexed citations
13.
Sutherland, C. Simone, Zanfina Ademi, Nadine Schur, et al.. (2019). Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland. BMJ Open. 9(11). e031325–e031325. 2 indexed citations
14.
Bhadhuri, Arjun, Hareth Al‐Janabi, Sue Jowett, & Kate Jolly. (2019). Incorporating Household Spillovers in Cost Utility Analysis: A Case Study Using Behavior Change in COPD. International Journal of Technology Assessment in Health Care. 35(3). 212–220. 5 indexed citations
15.
Turner, David, Tracey Sach, Diana Bilton, et al.. (2019). Health State Utility Data in Cystic Fibrosis: A Systematic Review. PharmacoEconomics - Open. 4(1). 13–25. 8 indexed citations
16.
Turner, David, Tracey Sach, Diana Bilton, et al.. (2019). Health economic modelling in Cystic Fibrosis: A systematic review. Journal of Cystic Fibrosis. 18(4). 452–460. 4 indexed citations
17.
Bhadhuri, Arjun, et al.. (2019). Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland. Swiss Medical Weekly. 149(5152). w20170–w20170. 20 indexed citations
18.
Sekoni, Adekemi, et al.. (2017). The effects of educational curricula and training on LGBT‐specific health issues for healthcare students and professionals: a mixed‐method systematic review. Journal of the International AIDS Society. 20(1). 21624–21624. 194 indexed citations
19.
Bhadhuri, Arjun, Sue Jowett, Kate Jolly, & Hareth Al‐Janabi. (2017). A Comparison of the Validity and Responsiveness of the EQ-5D-5L and SF-6D for Measuring Health Spillovers: A Study of the Family Impact of Meningitis. Medical Decision Making. 37(8). 882–893. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aviva G. Nathan Breakdown of academic impact, for papers by Rachel Adler Breakdown of academic impact, for papers by Chien‐Ching Li Breakdown of academic impact, for papers by Sarah Wylie Breakdown of academic impact, for papers by Chasity Burrows Walters Breakdown of academic impact, for papers by Karen Maxwell Breakdown of academic impact, for papers by Anton M. Palma Breakdown of academic impact, for papers by Gunna Kilian Breakdown of academic impact, for papers by David A. Ramirez Breakdown of academic impact, for papers by Bahar Yüksel
Rankless by CCL
2026